Sales Professional – Business Development (Retainer Contract)
Boost your chances before you apply.
Cornucopia Biosciences
US
Summary
The role involves building and managing an outbound sales pipeline for enterprise and mid-size pharma and biotech accounts. You will own the full sales cycle from discovery and negotiation to closing deals while collaborating with founders on strategy.
Job Description
About the role
Cornucopia Bio is an AI-native automation company operating at the intersection of assay execution and lab automation. We're looking for a high-performing sales operator — someone who can build pipeline from scratch, navigate complex pharma and biotech organizations, and close deals independently in an early-stage environment.
This is a 90-day retainer engagement with strong commission upside. Built for an operator who thrives on autonomy and wants real skin in the game.
Compensation
- Monthly retainer: $3,333/month ($10,000 total over 90 days)
- Commission: 15% of revenue generated, paid on cash received
- Tiered option: 15% on first $50K closed · 20% on revenue beyond $50K
- Alternative structure available: $5K retainer + 20–25% commission for the right candidate
What you'll own
- Run outbound pipeline across enterprise and mid-size pharma and biotech accounts — email, LinkedIn, and warm network introductions
- Target 8–15 qualified meetings per week from day one
- Own deals end-to-end: discovery, follow-up, negotiation, and close
- Collaborate with founders on pricing, positioning, and proposal strategy
- Develop and manage relationships across assay execution (qPCR, ELISA) and lab automation buyers
- Surface market intelligence — customer pain points, competitive signals, and messaging feedback
- Drive strategic introductions and partnership conversations
Performance milestones
- Day 30: At least 20 qualified meetings completed and early pipeline forming. Engagement reviewed at this stage — insufficient pipeline is grounds for early termination.
- Day 60: Active pipeline with $25K+ in qualified opportunities progressing toward close.
- Day 90: Closed revenue target reached. Both parties decide to extend, convert, or conclude the engagement.
Who you are
- Proven track record selling into pharma, biotech, or life sciences — you understand how buyers in these organizations think and buy
- A hunter who can both source and close, without waiting for inbound leads
- Comfortable operating in an early-stage, founder-led company where processes are still forming
- Adept at outbound prospecting — you have a methodology and a personal network you can activate quickly
- Familiarity with assay workflows (qPCR, ELISA) and/or lab automation is a meaningful advantage
- Self-directed, accountable, and transparent about what's working and what isn't
Terms & exclusivity
- Either party may terminate with 7 days' written notice
- Immediate termination if no meaningful pipeline is established by day 30, or if engagement expectations are not met
- Overlapping client engagements must be disclosed at the time of signing
- Cannot represent direct competitors in lab automation or assay execution during this term
- Commission is paid on cash received, not contract signature date
How to apply
Submit your application with a brief note on your most relevant pharma or biotech sales experience and a specific example of a deal you sourced and closed independently.
Cornucopia Bio aims to get drugs to patients faster.
We start by eliminating the biggest bottlenecks in R&D. Today, automation is the obvious answer to speeding up discovery — but it’s often trapped behind layers of complexity, custom scripts, and specialized engineers.
We believe automation shouldn’t be reserved for experts in machinery — it should be in the hands of experts in therapeutic areas. CornucopiaBio bridges that gap by making lab automation intuitive, conversational, and accessible to every scientist.
By turning natural language into executable lab workflows, we multiply the speed of experiment design, execution, and iteration — helping scientists move from idea to insight faster than ever.
Faster science, fewer bottlenecks.
cornucopiabio.com
Company size
2-10 employees
Industry
Software Development
Org type
Privately Held
Headquarters
San Francisco, CA
Cornucopia Bio aims to get drugs to patients faster.
We start by eliminating the biggest bottlenecks in R&D. Today, automation is the obvious answer to speeding up discovery — but it’s often trapped behind layers of complexity, custom scripts, and specialized engineers.
We believe automation shouldn’t be reserved for experts in machinery — it should be in the hands of experts in therapeutic areas. CornucopiaBio bridges that gap by making lab automation intuitive, conversational, and accessible to every scientist.
By turning natural language into executable lab workflows, we multiply the speed of experiment design, execution, and iteration — helping scientists move from idea to insight faster than ever.
Faster science, fewer bottlenecks.
cornucopiabio.com
Company size
2-10 employees
Industry
Software Development
Org type
Privately Held
Headquarters
San Francisco, CA